London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
If the Maverick capital rumour is true, that's great news.
Lee Ainslie, the founder apparently says that their goal is to know more than any noninsider about every one of the companies in which they invest.
Great news. But its a high bar in the case of Synarigen. Has he read this board? Does he know PMJH? ;-)
They were in CINE, along with Polyg. Small world eh.
Thanks for the heads up, good to know of increased interest, all bodes well.
All we need is a Tweet from RM at Sunseeker with a huge grin asking if they can do him something a bit bigger.
Floridajoe - Yes
Anybody heard of the Maverick Capital interest?
Your boat is clearly being pushed out M, I hope also to be able to add a little homemade nettle cordial to the white spirit in the shed this year but still a bit to do. A seemingly unique opportunity created by a perfect storm. I have become heavily invested and Invested in a way I never anticipated.I cannot begin to imagine doing all this again, my first and last big play although I have learnt a great deal over the last 11 months.
Just looking at the sells which is double the buys on this site yet good price rise so far someone said earlier we could have £2 by Friday MMM not so sure
Held on to all my shares since buying early April 2020 and topping up along the way. Loved to have traded it but didn't.
Hands firmly sat on.....been here 19 months.......what's another 2 !!
Just was offered 196p to sell 45,000 shares (I declined). Looks like 200p shortly, then 500p when I shall be tempted to sell half. Average buy price now is over 20p.
Agree AJ. Whenever there has been SNG specific news the SP seems to rise (although not always) only to return to (or be brought down to by Poloygon?) the placing level of 170/175. Maybe this rise is more solid as there are external factors at play?
It’s increasingly likely as results get closer.
I think trading in out is getting much more risky now. Its so close to highly visible shareholder demand pull from a totally new pool of non scientific based investors. I'm staying in. You've got to be in it to win it! All it will take is more positive news and awareness awakening from anywhere not just SPRINTER readout.
Woodstock1970. Maybe so, it has happened every other time we have a rise and I’ve always thought of trading but never have. Something just feels different since the new variant news, I feel there’s more sticky hands than ever before. Time will tell.
AJ316. No is the answer to your question unfortunately. Until P3 results are released the stock is likely to blow in the wind.
Will be getting her to stick to the small glass of Bristol Cream, H2, but have located the Babycham glasses in the loft and put the ****tails sticks and those cherry things on order. For info: first time for many years that I have anticipated a happy event especially where my market dabblings are concerned but the logic behind the SNG campaign has always made sense and always looked to be a good opportunity to stick one over the O and C lobby smarta***s and the big boys. GLU2
Anyone else get the feeling once we break £2 now with momentum and timing we may be able to hold and stay above it for the first time
Full details of the FDA meeting here
https://www.fda.gov/advisory-committees/advisory-committee-calendar/november-30-2021-antimicrobial-drugs-advisory-committee-meeting-announcement-11302021-11302021
Cant even begin to imagine what the SP would do if SNG were in an all day live broadcast meeting for EUA.
Waite,
The FDA is meeting to discuss the Merck pill EUA tomorrow. If there are going to be games played with the share price it could be on the back of this news.
However, this comment in the Numis note is of interest....
"Indeed, we now understand that the UK Chief Medical Officer has doubts about Merck's Molnupiravir, although whether this is due to the new variant, the potential to be "supercharging new viral variants" (Source: Forbes) or the concerning mutagenic safety profile is to us uncertain."
If FDA throws out the Merck EUA application or significantly limits is use case then this may move the SP higher considering they already have over $2billion in orders with the US government.
Can Mrs M anticipate an upgrade to Babycham over the festive season or are you holding off on the extravagance until a few weekends after New Year? Gl M
CityTrader - that's helpful, thanks.
I was literally finger hovering over topping up a substantial amount last week. I'm keen to know if it's going to correct, and if this is indeed overbought and stochastic. Kicking self for not trusting myself and going for it when it was 172 :S
Don't want to be waiting for the dip that never happens.
Either way, this is so very exciting.
I've given a lot of thought to where the SP will soon be. We are most likely to be taken over by big pharma who with all their global marketing and production facilities would soon make any purchase very profitible. There is a second option whereby SNG licence the product and earn a nice ongoing income for very little effort.
The reason I feel a buyout is more probable is because the initial Directors shareholders are now in their later stages of life and must be thinking of retirement soon? Though against this is the thought that they really are not needing more cash than they could ever spend!
Now for the valuation. Working on £1Bn of value makes the SP worth £5 A fair valuation could be about £5Bn or thereabouts. However when Merck recently announced their new pill its value jumped by £20Bn. So we can see £100 per share.
For me I am looking at about £15-20 per share but the potential here is huge.
engine's warming up nicely, speeds of £2.00 coming asap.
Pleased I stayed in over the weekend: Mrs M a bit happier now too. Not quite as exciting as "Manic Monday" but rather more significant I feel. Well done ALTHs.
Many thanks MrCrumpet. Yes thankfully spotted the sensible ones. For those unscrupulous ones on here, I understand there's a filter function - so will utilise that if necessary :)
Waite, The 35 day secondary endpoints complete around the 15th December and data will not be unblinded until then. Company has indicated toppling data early 2022 so that should be the expectation but recent events may help to bring that forward but that is a big maybe IMO.